CSF2 and COVID-19: Conversely, significantly higher levels of GM-CSF, IFN-β, IL-10, and IL-2 and low levels of Eotaxin, IL-4, IL-5, MCP-1, and MIP-1β, were distinctive to Non-SOT COVID-19 patients relative to HCs, but not in SOTRs.